Health Care & Life Sciences » Pharmaceuticals | ECO Animal Health Group PLC

ECO Animal Health Group PLC | Ownership

Companies that own ECO Animal Health Group PLC

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Schroder Investment Management Ltd.
7,391,051
11.15%
900,662
0.03%
05/02/2017
Liontrust Investment Partners LLP
7,346,720
11.08%
4,972,102
0.65%
09/01/2018
AXA Investment Managers UK Ltd.
7,344,069
11.08%
515,402
0.19%
09/21/2017
M&G Investment Management Ltd.
6,513,000
9.82%
-650,862
0.07%
07/07/2017
Old Mutual Global Investors (UK) Ltd.
5,582,025
8.42%
-3,473,069
0.11%
07/16/2018
Standard Life Investments Ltd.
4,440,407
6.7%
1,438,407
0.05%
07/05/2018
Hargreave Hale Ltd.
3,335,300
5.03%
56,460
0.24%
09/18/2017
Invesco Asset Management Ltd.
2,025,491
3.06%
1,604,491
0.02%
05/02/2017
Schroder Investment Management North America, Inc.
1,200,000
1.81%
0
0.04%
05/01/2018
Royal London Asset Management Ltd.
779,000
1.18%
0
0.01%
05/01/2018

About ECO Animal Health Group

View Profile
Address
78 Coombe Road
New Malden Surrey KT3 4QS
United Kingdom
Employees -
Website http://ecoanimalhealthgroupplc.com
Updated 07/08/2019
ECO Animal Health Group Plc engages in the development, registration and marketing of pharmaceutical products for animals. It operates through the following geographical segments: Corporate or United Kingdom; Europe; Far East; Latin America; North America; and Middle East and Africa. It distributes its antibiotics and bacterial infection treatments under the following brands: Aivlosin, Ecomectin, Ecoheart, Ecotraz, Ecomintic, Chlortetracycline, and Oxytetracycline.